Generic Name: Dapagliflozin
Brand Name: Forxiga
Manufacturer: AstraZeneca Canada Inc.
Indications: Diabetes mellitus (Type 2)
Submission Type: Initial
Project Status: Complete
Date Recommendation Issued: November 20, 2015
Recommendation Type: List with clinical criteria and/or conditions